Skip to main content

Hakho Lee

NIH Rank #1507
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9797123Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$4.2M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#1,507
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Hakho Lee. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Hakho Lee as a PI. Multi-PI records show the full award amount for context.

  • 5U01CA284982-02U01
    Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array
    $894.2K
    award amount
  • 5R01HL163513-02R01
    High-throughput Phenotyping of iPSC-derived Airway Epithelium by Multiscale Machine Learning Microscopy
    $759.3K
    award amount
  • 5R01CA264363-04R01
    High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
    $629.2K
    award amount
  • 5R01CA239078-05R01
    Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring
    $578.6K
    award amount
  • 5R01CA237500-05R01
    Standardized Molecular Analyses of Glioma EVs
    $557.5K
    award amount
  • 5U01CA279858-02U01
    Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach
    $527.5K
    award amount
  • 5R21CA267222-03R21
    3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids
    $223.8K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Hakho Lee as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1507
  6. 2024
    Entered Top 25% Nationally
    Ranked #1507
  7. 2024
    Entered Top 10% Nationally
    Ranked #1507
  8. 2025
    $5M Cumulative Funding
  9. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2025
    R01 Grant Holder
  11. 2025
    Program/Center Grant Leader
  12. 2026
    $10M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Hakho Lee.